Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-18

Clinical Trial Update: Safety and Efficacy Study for Various Skin Conditions [NA]

View source ↗

Summary

This entry notes a completed safety and efficacy study by Sciton for dyschromia and photodamaged skin, with no results shown in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sciton | Conditions: Dyschromia, Photodamaged Skin | NA | Status: COMPLETED